Literature DB >> 12031975

Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans.

André Carpentier1, Bruce W Patterson, Nathalie Leung, Gary F Lewis.   

Abstract

One important mechanism whereby obesity-associated insulin resistance leads to VLDL overproduction is thought to be by the increased flux of free fatty acids (FFAs) from extrahepatic tissues to liver, which arises as a direct consequence of impaired insulin action in adipose tissue and skeletal muscle. The aim of the present study was to address whether direct measures of peripheral tissue insulin sensitivity with regard to FFAs and glucose in the fasting state are good predictors of postabsorptive VLDL triglyceride secretion rate (VLDL-TG ASR) in humans, independent of obesity. Eighteen healthy control subjects, after an overnight fast, underwent three studies 3 weeks apart, in random order. Study 1: VLDL-TG levels, fractional clearance rate (per h), and VLDL-TG ASR were determined after an intravenous bolus of [1,1,2,3,3-(2)H(5)] glycerol. Study 2: Insulin sensitivity (S(I)), acute insulin response (AIR), and acute C-peptide response to glucose were assessed by frequently sampled intravenous glucose tolerance test using the minimal model approach. Study 3: Insulin-mediated suppression of plasma FFAs (k) and insulin clearance were assessed in response to a low-dose stepwise intravenous insulin infusion. BMI (R(2) = 0.54), AIR, and fasting insulin levels were positively and S(I) negatively correlated with VLDL-TG ASR, but there was no significant association with plasma FFAs or k. Only BMI remained significantly associated with VLDL-TG ASR in multivariate analysis. The best multivariate model for VLDL-TG ASR (R(2) = 0.61, P = 0.0008) included BMI (P = 0.0008) and S(I) (P = 0.12, inversely correlated). VLDL-TG secretion is predicted by BMI, independently of direct measures of insulin sensitivity. The sensitivity to insulin's acute suppressive effect on plasma FFA levels during fasting is not an important determinant of postabsorptive VLDL-TG secretion in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031975     DOI: 10.2337/diabetes.51.6.1867

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans.

Authors:  C Xiao; A Giacca; A Carpentier; G F Lewis
Journal:  Diabetologia       Date:  2006-04-05       Impact factor: 10.122

Review 2.  Metabolic actions of insulin in men and women.

Authors:  Faidon Magkos; Xuewen Wang; Bettina Mittendorfer
Journal:  Nutrition       Date:  2010-04-14       Impact factor: 4.008

3.  Effects of exercise on VLDL-triglyceride oxidation and turnover.

Authors:  Esben Sondergaard; Iben Rahbek; Lars P Sørensen; Jens S Christiansen; Lars C Gormsen; Michael D Jensen; Søren Nielsen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-08       Impact factor: 4.310

Review 4.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

Review 5.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.

Authors:  Andréanne Trottier; Marie-Claude Battista; David H Geller; Brigitte Moreau; André C Carpentier; Judith Simoneau-Roy; Jean-Patrice Baillargeon
Journal:  Fertil Steril       Date:  2012-09-15       Impact factor: 7.329

7.  Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.

Authors:  Sriram Gubbi; Ranganath Muniyappa; Susmeeta T Sharma; Shivraj Grewal; Raven McGlotten; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

8.  Systemic free fatty acid disposal into very low-density lipoprotein triglycerides.

Authors:  Christina Koutsari; Manpreet S Mundi; Asem H Ali; Bruce W Patterson; Michael D Jensen
Journal:  Diabetes       Date:  2013-02-22       Impact factor: 9.461

9.  Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome.

Authors:  Soren Harnois-Leblanc; Andréanne Trottier; Samuel Leblanc; Marie-Claude Battista; David H Geller; Jean-Patrice Baillargeon
Journal:  Reprod Biol Endocrinol       Date:  2017-07-24       Impact factor: 5.211

10.  Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes.

Authors:  Chih-Neng Hsu; Chia-Hsuin Chang; Yu-Sheng Lin; Jou-Wei Lin; James L Caffrey
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.